National and Kapodistrian University of Athens
Μοριακός χαρακτηρισμός και μελέτη in vitro δραστικότητας αντιμικροβιακών έναντι εντεροβακτηριακών που παράγουν καρβαπενεμάσες
Abstract
dc:descriptionK.pneumoniae has emerged as a major clinical and public health threat. Klebsiella pneumoniae bacteremia is responsible for reduced life expectancy, increased rates of treatment failure worldwide and increased healthcare spending. The management of K.pneumoniae infections has become challenging due to the emerging antimicrobial resistance. Of special concern is the rise of carbapenem-resistant isolates. Within the European countries, carbapenem-resistant K.pneumoniae are most widespread in the Mediterranean Region with a prevalence of approximately 60% in Greece. Resistance to carbapenems in K.pneumoniae involves multiple mechanisms, including the production of carbapenemases (e.g., KPC, NDM, VIM, OXA-48) and alterations in outer membrane permeability (mutation or loss of porins and upregulation of efflux systems). The rapid dissemination of carbapenem resistant Klebsiella pneumoniae is driven by several successful clones worldwide. Antibiotics active against carbapenem-resistant (CR) K. pneumoniae strains are diminishing at an alarming rate. Therefore, until recently, older antibiotics with high toxicity, such as colistin, fosfomycin, tigecycline and aminoglycosides, were employed. Fortunately, a variety of new drugs have been developed in recent years against MDR gram-negative infections. We aimed to investigate the CRKP clonal lineages, their antibiotic resistance determinants, and their potential transmissions in a tertiary care hospital located in Athens, Greece. A total of 586 non-duplicate carbapenem-resistant K.pneumoniae strains were collected from a tertiary hospital in Greece from 10/2003-12/2021. They originated exclusively from blood cultures. Antimicrobial susceptibility testing was performed and carbapenemase genes were detected. Overall, the carbapenemases produced included KPC (65.87%, n=386/586), NDM (10.75%, n=63/586), VIM (16.38%, n=96/586), OXA-48 carbapenemases (1.71%, n=10/586). Simultaneous detection of two carbapenemase genes was found in 5.29% (n=31/586) isolates: blaKPC/ blaVIM (4.78%, n=28/586), blaKPC/ blaNDM (0.17%, n=1/586), blaNDM/ blaVIM (0.17%, n=1/586) and blaNDM/ blaOXA-48 (0.17%, n=1/586). The most prevalent carbapenemase gene was blaKPC, followed by VIM. Among KPC strains, KPC-2 was the predominant KPC carbapenemase, followed by KPC-3. The blaKPC-23 gene was detected in 3 K.pneumoniae KPC isolates. The investigated carbapenem-resistant K.pneumoniae strains were resistant to amynoglycosides at a percentage ranging from 45.56% to 95.05% (with gentamicin harboring the lowest rate of resistance and tobramycin the highest) and almost all were resistant to fluoroquinolones (95.90%) and cotrimoxazole (89,76%). 36.01% of the carbapenem-resistant strains were resistant to colistin and 32.42% exhibited MIC tigecycline above 1mg/l. Ceftazidime-avibactam was proven highly efficient in vitro against blaKPC and blaOXA-48 positive strais, with only 2 KPC strains recorded as resistant. It is worth mentioning that we recorded 58 strains with intermediate MIC meropenem (4 mg/L ≤ MIC≤ 8 mg/L) and 10 strains with MIC meropenem ≤ 2 mg/L. Whole genome sequencing (WGS) was performed on the Illumina platform to characterize 209 of these isolates. 74% (n=155) of 209 isolates belonged to three major clonal lineages; ST258 (n=108), ST147 (n=29), and ST11 (n=18). Acquired carbapenemase genes were the mechanisms of resistance in 205 isolates (blaKPC, n=123; blaVIM, n=56; blaNDM, n=20; blaOXA-48, n=6). Strong associations (p=0.0004) were observed between carbapenemase genes and clonal lineages. BlaVIM-1-carrying ST147 strains were first isolated during the early sampling period in 2003, followed by the emergence of blaKPC-2-carrying ST258 in 2006, and blaNDM-1-carrying ST11 in 2013. Analysis of genetic distances between the isolates revealed six potential transmission events. Acquisition of multiple carbapenemase genes by Klebsiella pneumoniae (Kp) is also an emerging public health threat. We tried to elucidate the population structure of Kp blood isolates carrying two different carbapenemase genes and identify the mechanism facilitating their dissemination. The study was conducted between 2014 and 2022. Twenty-four patients with bacteremia caused by Kp carrying two different carbapenemase genes were identified. All 24 blood isolates were analyzed by short-read genome sequences supplemented by long reads in a selected number of isolates. All isolates carried blaKPC (23 blaKPC-2, 1 blaKPC-3) and blaVIM-1 genes, along with a variety of antimicrobial resistance determinants. The isolates were clustered in six clonal lineages (ST39, ST147, ST323, ST258, ST3035, and ST340). Long-read genome sequences demonstrated that each carbapenemase gene was located in a separate group of plasmids: the blaKPC-2 on a fusion of IncFIB(pQil) and IncFII(K) plasmids, the blaKPC-3 on IncX3, the blaVIM-1 on IncC, or a fusion of the IncFIB(pNDM-Mar) and IncHI1B(pNDM-MAR) plasmids. Comparison of plasmid content of eight isolates carrying a single carbapenemase gene with eight isolates carrying two carbapenemase genes, matched by clonal lineages, revealed that the second carbapenemase gene was acquired by addition of another plasmid. Identical plasmids were found within the same lineage and across lineages. These findings suggest that dissemination of carbapenemase genes in our hospital setting was driven by multiple plasmids across a variety of highly efficient clones.In conclusion, the current study highlighted the high rates of resistance of CRKPs in older antibiotics, identified the underlying resistance genes, and described their relative frequency and evolution over time. Through genome sequencing, the corresponding clones (sequence types) were identified and correlated with the various carbapenemase genes. These genes were mapped on plasmids and these data were used to document intra-hospital dissemination events of the above clones. Applying the methodology of the current study on a larger scale will probably provide important data for a better understanding of the dispersion of CRKP strains in Greece, helping thus to control it.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Rigatou, Anastasia
- Ρηγάτου, Αναστασία
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61637